Video Experimental Relacionado
Updated: Jan 8, 2026

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
¿El concentrado de complejo de protrombina reemplazará al plasma en el sangrado quirúrgico cardíaco en América del
Justyna Bartoszko1,2,3, Nadia Gabarin4, Kenichi Tanaka5
1Department of Anesthesia and Pain Management, University Health Network, Sinai Health, Women's College Hospital, University of Toronto.
El concentrado de complejo de protrombina de cuatro factores (4F-PCC) muestra una mayor eficacia y seguridad que el plasma para el tratamiento del sangrado en cirugía cardíaca. Esta revisión destaca la evidencia actual que apoya el 4F-PCC como una opción de tratamiento beneficiosa.
Videos de Conceptos Relacionados
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Cardiac Catheterization I: Pre-Procedure Overview

